These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 25973904)

  • 1. Study on the inter- and intra-peptide salt-bridge mechanism of Aβ23-28 oligomer interaction with small molecules: QM/MM method.
    Boopathi S; Kolandaivel P
    Mol Biosyst; 2015 Jul; 11(7):2031-41. PubMed ID: 25973904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of phenolic OH groups of flavonoid compounds with H-bond formation ability to suppress amyloid mature fibrils by destabilizing β-sheet conformation of monomeric Aβ17-42.
    Andarzi Gargari S; Barzegar A; Tarinejad A
    PLoS One; 2018; 13(6):e0199541. PubMed ID: 29953467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted studies on the interaction of nicotine and morin molecules with amyloid β-protein.
    Boopathi S; Kolandaivel P
    J Mol Model; 2014 Mar; 20(3):2109. PubMed ID: 24567151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of a water-soluble fullerene derivative with amyloid-β protofibrils: dynamics, binding mechanism, and the resulting salt-bridge disruption.
    Zhou X; Xi W; Luo Y; Cao S; Wei G
    J Phys Chem B; 2014 Jun; 118(24):6733-41. PubMed ID: 24857343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomic-level study of the effects of O4 molecules on the structural properties of protofibrillar Aβ trimer: β-sheet stabilization, salt bridge protection, and binding mechanism.
    Sun Y; Xi W; Wei G
    J Phys Chem B; 2015 Feb; 119(7):2786-94. PubMed ID: 25608630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scrutiny of the mechanism of small molecule inhibitor preventing conformational transition of amyloid-β
    Shuaib S; Goyal B
    J Biomol Struct Dyn; 2018 Feb; 36(3):663-678. PubMed ID: 28162045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico and in vitro studies to elucidate the role of Cu2+ and galanthamine as the limiting step in the amyloid beta (1-42) fibrillation process.
    Hernández-Rodríguez M; Correa-Basurto J; Benitez-Cardoza CG; Resendiz-Albor AA; Rosales-Hernández MC
    Protein Sci; 2013 Oct; 22(10):1320-35. PubMed ID: 23904252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morin inhibits the early stages of amyloid β-peptide aggregation by altering tertiary and quaternary interactions to produce "off-pathway" structures.
    Lemkul JA; Bevan DR
    Biochemistry; 2012 Jul; 51(30):5990-6009. PubMed ID: 22762350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrochalcone molecules destabilize Alzheimer's amyloid-β protofibrils through binding to the protofibril cavity.
    Jin Y; Sun Y; Lei J; Wei G
    Phys Chem Chem Phys; 2018 Jun; 20(25):17208-17217. PubMed ID: 29900443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Destabilizing Alzheimer's Abeta(42) protofibrils with morin: mechanistic insights from molecular dynamics simulations.
    Lemkul JA; Bevan DR
    Biochemistry; 2010 May; 49(18):3935-46. PubMed ID: 20369844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An α-helix mimetic oligopyridylamide, ADH-31, modulates Aβ
    Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2020 Dec; 22(48):28055-28073. PubMed ID: 33289734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory mechanism of a fullerene derivative against amyloid-β peptide aggregation: an atomistic simulation study.
    Sun Y; Qian Z; Wei G
    Phys Chem Chem Phys; 2016 May; 18(18):12582-91. PubMed ID: 27091578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fe(2+) binding on amyloid β-peptide promotes aggregation.
    Boopathi S; Kolandaivel P
    Proteins; 2016 Sep; 84(9):1257-74. PubMed ID: 27214008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atomistic mechanism of polyphenol amyloid aggregation inhibitors: molecular dynamics study of Curcumin, Exifone, and Myricetin interaction with the segment of tau peptide oligomer.
    Berhanu WM; Masunov AE
    J Biomol Struct Dyn; 2015; 33(7):1399-411. PubMed ID: 25093402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation.
    Feng Y; Wang XP; Yang SG; Wang YJ; Zhang X; Du XT; Sun XX; Zhao M; Huang L; Liu RT
    Neurotoxicology; 2009 Nov; 30(6):986-95. PubMed ID: 19744518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Explicit solvent molecular dynamics simulations of Aβ peptide interacting with ibuprofen ligands.
    Lockhart C; Kim S; Klimov DK
    J Phys Chem B; 2012 Nov; 116(43):12922-32. PubMed ID: 23051147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the inhibitory mechanism of a resveratrol and clioquinol hybrid against Aβ
    Saini RK; Shuaib S; Goyal D; Goyal B
    J Biomol Struct Dyn; 2019 Aug; 37(12):3183-3197. PubMed ID: 30582723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.